AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 270: R630-R635, 1996;
0363-6119/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parekh, N.
Right arrow Articles by Steinhausen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parekh, N.
Right arrow Articles by Steinhausen, M.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 270, Issue 3 630-R635, Copyright © 1996 by American Physiological Society


ARTICLES

Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney

N. Parekh, L. Dobrowolski, A. P. Zou and M. Steinhausen
Department of Physiology, University of Heidelberg, Germany.

This study compared the vasoconstrictor action of angiotensin II (ANG II) and norepinephrine (NE) with different levels of nitric oxide (NO) in the kidney of anesthetized rats. In one series of experiments, the drugs were infused intravenously, and systemic NO content was reduced by a NO synthase inhibitor, nitro-L-arginine methyl ester (L-NAME). L-NAME significantly enhanced the renal blood flow (RBF) reduction produced by ANG II from 26 to 49%, but it had no significant effect on the change in RBF induced by NE. Medullary blood flow was not influenced by either ANG II or NE given alone or given after L-NAME. In the second series of experiments, all drugs were infused into the renal artery to avoid their systemic and, hence, extrarenal effects. In these experiments, renal content of NO was increased by the NO donor sodium nitroprusside (SNP), decreased by L-NAME, or restored by replacing endogenous NO by exogenous NO (L-NAME + SNP). Effects of both ANG II and NE on RBF were similarly and significantly attenuated by SNP (60% of control), enhanced by L-NAME (200% of control), and restored by L-NAME + SNP (90% of control, not significant). Our results indicate that NO attenuates the renal vasoconstriction due to ANG II or NE and that the antagonism between vasoconstrictors and NO is not due to a constrictor-induced production of NO because exogenous and endogenous NO were equally effective.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. M. O'Connor, M. M. Kett, W. P. Anderson, and R. G. Evans
Renal medullary tissue oxygenation is dependent on both cortical and medullary blood flow
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F688 - F694.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst
NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. W. Rajapakse, R. J. Roman, J. R. Falck, J. J. Oliver, and R. G. Evans
Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R181 - R187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. A. Fortepiani, M. C. O. Ruiz, F. Passardi, M. D. Bentley, J. Garcia-Estan, E. L. Ritman, and J. C. Romero
Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F852 - F860.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Sarkis, K. L. Liu, M. Lo, and D. Benzoni
Angiotensin II and renal medullary blood flow in Lyon rats
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F365 - F372.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. PATZAK, R. MROWKA, E. STORCH, B. HOCHER, and P. B. PERSSON
Interaction of Angiotensin II and Nitric Oxide in Isolated Perfused Afferent Arterioles of Mice
J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1122 - 1127.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. W. Dukacz, M.-G. Feng, L.-F. Yang, R. M. K. W. Lee, and R. L. Kline
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1076 - R1084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. C. Schoonmaker, R. W. Fallet, and P. K. Carmines
Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus
Am J Physiol Renal Physiol, February 1, 2000; 278(2): F302 - F309.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. D. Symons, C. L. Stebbins, and T. I. Musch
Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats
J Appl Physiol, August 1, 1999; 87(2): 574 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Bauer, C. Dau, A. Cavarape, F. Schaefer, H. Ehmke, and N. Parekh
ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H1 - H7.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. T. Nowicki
Effects of sustained low-flow perfusion on the response to vasoconstrictor agents in postnatal intestine
Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1408 - G1416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Ortiz, L. A. Fortepiani, F. M. Ruiz-Marcos, N. M. Atucha, and J. Garcia-Estan
Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R760 - R766.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online